SCHEMBL10242486

SCHEMBL10242486

CN(CC1CC1)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27945144 0.98 ALOX5 (0.56)
SCHEMBL29629110 0.91 ALOX5 (0.61)
SCHEMBL27683141 0.91 ALOX5 (0.61)
SCHEMBL24630130 0.80 ALOX5 (0.38)
SCHEMBL12164426 0.78
SCHEMBL15017272 0.78
SCHEMBL9954309 0.76
SCHEMBL15998881 0.74 ALOX5 (0.40)
SCHEMBL1627877 0.73
SCHEMBL10128321 0.73 ALOX5 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016001789-A1 PYRIMIDINE DERIVATIVES AS PI3K INHIBITORS FOR USE IN THE TREATMENT OF CANCER PFIZER INC. (US) 2016-01-07 WO disclosed
WO-2012085167-A1 METABOTROPIC GLUTAMATE RECEPTOR MODULATORS MERZ PHARMA GMBH & CO. KGAA (DE) 2012-06-28 WO disclosed
CN-1229350-C New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias ASTRAZENECA AB (SE) 2005-11-30 CN disclosed